Cargando...

Radium-223 in treatment of castration-resistant prostate cancer with skeletal metastases

More than 90 % of patients with metastatic castration-resistant prostate cancer (CRPC) have radiologically confirmed skeletal metastases. Traditional treatment methods such as administration of painkillers, external beam therapy, bisphosphonates or denosumab, as well as injections of strontium-89 or...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. B. Matveev, A. S. Markova
Formato: Artigo
Lenguaje:Russo
Publicado: ABV-press 2017-09-01
Colección:Onkourologiâ
Materias:
Acceso en línea:https://oncourology.abvpress.ru/oncur/article/view/721
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!